Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

AcuCort

0.41 SEK0.00 %23/10 17:29
Less than 1K followers

ACUC

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
0.00 %
-16.94 %
-35.80 %
-49.13 %
-32.17 %
-33.06 %
+17.39 %
-78.42 %
-84.05 %

AcuCort is a pharmaceutical company. The company develops and commercializes pharmaceuticals based on well-established substances with a focus on user-friendliness and ease of administration. The company's leading product is an oral film for the acute treatment of allergic reactions and other conditions with high medical demand. Products are aimed at patients and caregivers globally. AcuCort was founded in 2006 and is headquartered in Lund, Sweden.

Read more
Market cap
95.42M SEK
Turnover
17.66K SEK
Revenue
690K
EBIT %
-3,839.13 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
5/11
2026

Extraordinary general meeting '26

5/11
2026

Interim report Q3'26

All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release2026-10-14 08:30

AcuCort's Capital Markets Day - watch the presentation

AcuCort
Press release2026-10-14 08:30

AcuCorts kapitalmarknadsdag - se presentationen i efterhand

AcuCort
Press release2026-10-14 08:30

Investor Studios: AcuCorts kapitalmarknadsdag går nu att se i efterhand

AcuCort

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-10-06 09:08

Investor Studios: AcuCorts VD har ordet: Emission ska finansiera FDA-process & global expansion

AcuCort
Press release2026-10-06 09:00

AcuCort AB: AcuCort's CEO Jonas Jönmark to take part in live broadcast on rights issue and US expansion

AcuCort
Press release2026-10-06 09:00

AcuCort AB: AcuCorts VD Jonas Jönmark i direktsändning om företrädesemissionen och USA-satsningen

AcuCort
Press release2026-10-06 08:30

AcuCort AB: AcuCort bjuder in till kapitalmarknadsdag den 13 oktober

AcuCort
Press release2026-10-06 08:30

AcuCort AB: AcuCort invites investors to Capital Markets Day on 13 October

AcuCort
Press release2026-10-05 13:31

Analyst Group: Analyst Group kommenterar AcuCorts företrädesemission om ca 70,3 MSEK

AcuCort
Regulatory press release2026-10-05 08:50

Kallelse till extra bolagsstämma i AcuCort AB (publ)

AcuCort
Regulatory press release2026-10-05 08:45

AcuCort AB beslutar om en företrädesemission av units om initialt cirka 70,3 MSEK för att finansiera fortsatt arbete mot FDA-godkännande och påskynda kommersialiseringen samt upptar brygglån

AcuCort
Regulatory press release2026-10-05 08:45

AcuCort AB resolves on a rights issue of units of initially approximately SEK 70.3 million to finance continued efforts towards FDA approval and accelerate commercialization, and raises a bridge loan

AcuCort
Press release2026-09-28 13:05

AcuCort AB: AcuCort publishes September 2026 newsletter

AcuCort
Press release2026-09-28 13:05

AcuCort AB: AcuCort publicerar nyhetsbrev för september 2026

AcuCort
Regulatory press release2026-09-16 10:30

AcuCort AB: AcuCort beviljas finansiellt stöd av Region Skåne för expansion till USA

AcuCort
Regulatory press release2026-09-16 10:30

AcuCort AB: AcuCort awarded funding from Region Skåne to support its US expansion

AcuCort
Press release2026-09-07 15:15

Analyst Group: Analyst Group kommenterar AcuCorts beviljade varumärkesskydd av Zeqmelit® i Ukraina

AcuCort
Regulatory press release2026-09-07 13:35

AcuCort AB: AcuCorts läkemedel Zeqmelit® registrerat som varumärke i Ukraina

AcuCort
Regulatory press release2026-09-07 13:35

AcuCort AB: AcuCort's product Zeqmelit® registered as a trade mark in Ukraine

AcuCort
Press release2026-09-03 08:54

Investor Studios: AcuCorts VD har ordet: Zeqmelit® i vetenskapliga tidsskrifter

AcuCort